42 min
Questions Abound. The Short Coat
-
- Education
Interview season begins soon, which means it's time to worry about the weird questions you'll be asked during med school interviews. Kayla got in touch with us at our new Facebook Group, The Short Coat Student Lounge, and asked what strange or difficult questions Lisa Wehr, Liza Mann, Irisa Mahaparn, and new co-host Mackenzie Walhof had been asked when it was their turn. Kayla's question, of course, inspires Dave to have them try to play a game of Questions, at which all the co-hosts fail miserably. The FDA announced that it's seeking public comment on plans to reduce nicotine in cigarettes to sub-addictive levels. Interesting idea...but we have questions. Google is trying to give US mobile users who search for info about depression a link to a screening tool for the disease...but we have questions. One thing we don't question: our old friend Martin Shkreli's securities fraud trial jury selection transcripts were released, and let's just say the jury of his peers don't give a rat's butt about what he's actually on trial for...they hate him for the drug thing. What questions do you have for us? We'd love to hear your thoughts. Call us at 347-SHORTCT any time, join our Facbook group, and email theshortcoats@gmail.com.
Interview season begins soon, which means it's time to worry about the weird questions you'll be asked during med school interviews. Kayla got in touch with us at our new Facebook Group, The Short Coat Student Lounge, and asked what strange or difficult questions Lisa Wehr, Liza Mann, Irisa Mahaparn, and new co-host Mackenzie Walhof had been asked when it was their turn. Kayla's question, of course, inspires Dave to have them try to play a game of Questions, at which all the co-hosts fail miserably. The FDA announced that it's seeking public comment on plans to reduce nicotine in cigarettes to sub-addictive levels. Interesting idea...but we have questions. Google is trying to give US mobile users who search for info about depression a link to a screening tool for the disease...but we have questions. One thing we don't question: our old friend Martin Shkreli's securities fraud trial jury selection transcripts were released, and let's just say the jury of his peers don't give a rat's butt about what he's actually on trial for...they hate him for the drug thing. What questions do you have for us? We'd love to hear your thoughts. Call us at 347-SHORTCT any time, join our Facbook group, and email theshortcoats@gmail.com.
42 min